https://www.ushealthcarejournal.com/article/911586831-top-gelatin-capsules-manufacturer-expands-global-pharmaceutical-packaging-and-delivery-solutions US Healthcare Journal en PressRelease 2026-05-09T08:03:10+00:00 Top Gelatin Capsules Manufacturer Expands Global Pharmaceutical Packaging and Delivery Solutions https://www.ushealthcarejournal.com/article/911105419-pro-senior-placement-helps-families-navigate-difficult-conversations-about-assisted-living US Healthcare Journal en PressRelease 2026-05-09T05:15:00+00:00 Pro Senior Placement Helps Families Navigate Difficult Conversations About Assisted Living https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24175884-pro-senior-placement-2700x2160.jpeg https://www.ushealthcarejournal.com/article/911061805-smile-hair-clinic-highlights-long-fue-as-a-discreet-hair-transplant-option-in-turkey US Healthcare Journal en PressRelease 2026-05-09T00:00:00+00:00 Smile Hair Clinic Highlights Long FUE as a Discreet Hair Transplant Option in Turkey https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24849979-long-fue-2540x1479.jpeg https://www.ushealthcarejournal.com/article/911067948-smile-hair-clinic-highlights-manual-punch-fue-technique-in-istanbul US Healthcare Journal en PressRelease 2026-05-09T00:00:00+00:00 Smile Hair Clinic Highlights Manual Punch FUE Technique in Istanbul https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24850006-manual-punch-2000x1334.jpeg https://www.ushealthcarejournal.com/article/911468158-pda-contest-spotlights-the-importance-of-children-s-oral-health US Healthcare Journal en PressRelease 2026-05-08T21:01:46+00:00 PDA Contest Spotlights the Importance of Children’s Oral Health https://www.ushealthcarejournal.com/article/911464463-early-onset-colorectal-cancer-ttuhsc-expert-helps-navigate-confusing-trend US Healthcare Journal en PressRelease 2026-05-08T20:45:49+00:00 Early-Onset Colorectal Cancer: TTUHSC Expert Helps Navigate Confusing Trend https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24851516-photo-of-john-t-kidwell-m-d-4096x4096.jpeg https://www.ushealthcarejournal.com/article/911458313-center-for-family-services-toasts-the-palm-beach-power-behind-old-bags-luncheon-2026 US Healthcare Journal en PressRelease 2026-05-08T20:45:00+00:00 Center for Family Services Toasts the Palm Beach Power Behind Old Bags Luncheon® 2026 https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/20218432-logo-center-for-family-services-279x149.png https://www.ushealthcarejournal.com/article/909074482-esthetic-dentistry-puerto-vallarta-prioritizes-tooth-preservation-as-aggressive-smile-makeover-trends-grow US Healthcare Journal en PressRelease 2026-05-08T20:24:36+00:00 Esthetic Dentistry Puerto Vallarta Prioritizes Tooth Preservation as Aggressive Smile Makeover Trends Grow https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24845132-dental-veneers-in-mexico-befo-951x476.png https://www.ushealthcarejournal.com/article/911454850-zahn-implant-club-rebrands-as-fusion-dental-implants-to-reflect-expanded-vision-and-patient-experience US Healthcare Journal en PressRelease 2026-05-08T19:49:21+00:00 Zahn Implant Club Rebrands as Fusion Dental Implants to Reflect Expanded Vision and Patient Experience https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24851474-fusion-dental-implants-1563x1036.jpeg https://www.ushealthcarejournal.com/article/911453457-dr-tam-cummings-to-headline-power-of-the-mind-dementia-conference-hosted-by-arden-courts-in-bethlehem US Healthcare Journal en PressRelease 2026-05-08T19:44:53+00:00 Dr. Tam Cummings to Headline ‘Power of the Mind’ Dementia Conference Hosted by Arden Courts in Bethlehem https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24830419-power-of-the-mind-s-pa-780x386.png https://www.ushealthcarejournal.com/article/911445455-study-finds-dna-carrying-antibiotic-resistance-genes-can-remain-functional-after-common-lab-decontamination-steps US Healthcare Journal en PressRelease 2026-05-08T19:18:10+00:00 Study finds DNA carrying antibiotic resistance genes can remain functional after common lab decontamination steps https://www.ushealthcarejournal.com/article/911446214-how-medical-history-plays-a-role-in-the-add-diagnostic-process US Healthcare Journal en PressRelease 2026-05-08T19:12:34+00:00 How Medical History Plays a Role in the ADD Diagnostic Process https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/22244115-add3-1920x1280.jpeg https://www.ushealthcarejournal.com/article/909420870-profounda-health-beauty-s-innovative-rhinase-x-value-combo-pack-will-be-sold-in-126-walmart-stores-beginning-july-2026 US Healthcare Journal en PressRelease 2026-05-08T18:39:43+00:00 Profounda Health & Beauty's innovative Rhinase X Value Combo Pack will be sold in 126 Walmart Stores beginning July 2026 https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24757019-rhinase-x-combo-pack-1080x1080.png https://www.ushealthcarejournal.com/article/911436016-wellness-coach-copy-vault-launches-complete-done-for-you-copywriting-system-for-health-coaches US Healthcare Journal en PressRelease 2026-05-08T18:25:21+00:00 Wellness Coach Copy Vault Launches Complete Done-For-You Copywriting System for Health Coaches https://www.ushealthcarejournal.com/article/911140913-capital-linguists-provides-top-notch-certified-spanish-interpretation-and-translation-services-across-the-usa US Healthcare Journal en PressRelease 2026-05-08T17:21:50+00:00 Capital Linguists Provides Top-Notch Certified Spanish Interpretation and Translation Services Across the USA https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24850417-spanish-interpretation-services-1200x628.jpeg https://www.ushealthcarejournal.com/article/911412734-honoring-education-leaders-and-empowering-dreams-at-the-scribes-institute-13th-annual-mlk-gala-in-hartford US Healthcare Journal en PressRelease 2026-05-08T16:44:56+00:00 Honoring Education Leaders and Empowering Dreams at The Scribes Institute 13th Annual MLK Gala in Hartford https://www.ushealthcarejournal.com/article/911411524-clarity-family-therapy-services-expands-mental-health-support-in-los-angeles US Healthcare Journal en PressRelease 2026-05-08T16:31:09+00:00 Clarity Family Therapy Services Expands Mental Health Support in Los Angeles https://www.ushealthcarejournal.com/article/911163737-desert-moon-wellness-expands-access-to-advanced-recovery-and-wellness-therapies-in-las-vegas US Healthcare Journal en PressRelease 2026-05-08T16:19:28+00:00 Desert Moon Wellness Expands Access to Advanced Recovery and Wellness Therapies in Las Vegas https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24850533-janelle-and-cory-ardizzone-from-1200x675.jpeg https://www.ushealthcarejournal.com/article/911334296-atherosclerosis-drugs-market-analysis-report-2026-major-trends-growth-drivers-and-forecast-overview US Healthcare Journal en PressRelease 2026-05-08T15:12:35+00:00 Atherosclerosis Drugs Market Analysis Report 2026: Major Trends, Growth Drivers, and Forecast Overview https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/786757-tbrc-1024x302.jpeg https://www.ushealthcarejournal.com/article/911329228-in-depth-analysis-of-the-apixaban-market-key-opportunities-and-challenges US Healthcare Journal en PressRelease 2026-05-08T15:12:30+00:00 In-Depth Analysis of the Apixaban Market: Key Opportunities and Challenges https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/786757-tbrc-1024x302.jpeg https://www.ushealthcarejournal.com/article/911330363-the-aptamers-market-is-projected-to-achieve-a-value-of-us-9-83-billion-by-2030 US Healthcare Journal en PressRelease 2026-05-08T15:12:30+00:00 The Aptamers Market is projected to achieve a value of US $9.83 billion by 2030. https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/786757-tbrc-1024x302.jpeg https://www.ushealthcarejournal.com/article/911328301-anti-tumor-drugs-market-opportunities-market-share-growth-trends-competitive-landscape-and-forecast-to-2030 US Healthcare Journal en PressRelease 2026-05-08T15:12:29+00:00 Anti-Tumor Drugs Market: Opportunities, Market Share, Growth Trends, Competitive Landscape, and Forecast to 2030 https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/786757-tbrc-1024x302.jpeg https://www.ushealthcarejournal.com/article/911328820-antiviral-combination-therapy-market-expected-to-expand-at-a-7-8-cagr-until-2030-industry-analysis US Healthcare Journal en PressRelease 2026-05-08T15:12:29+00:00 Antiviral Combination Therapy Market Expected to Expand at a 7.8% CAGR Until 2030: Industry Analysis https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/786757-tbrc-1024x302.jpeg https://www.ushealthcarejournal.com/article/911387055-the-autoimmune-monoclonal-antibody-market-grow-at-a-cagr-of-8-1-between-2026-and-2030-104-57-billion-by-2030 US Healthcare Journal en PressRelease 2026-05-08T15:11:44+00:00 The Autoimmune Monoclonal Antibody Market grow at a CAGR of 8.1% between 2026 and 2030, $104.57 billion by 2030. https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/786757-tbrc-1024x302.jpeg https://www.ushealthcarejournal.com/article/911387807-avascular-necrosis-market-analysis-of-future-demand-and-leading-key-players-through-2030 US Healthcare Journal en PressRelease 2026-05-08T15:11:44+00:00 Avascular Necrosis Market: Analysis of Future Demand and Leading Key Players Through 2030 https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/786757-tbrc-1024x302.jpeg https://www.ushealthcarejournal.com/article/911384938-the-market-for-attention-deficit-hyperactivity-disorder-adhd-therapeutics-is-projected-to-us-17-85-billion-by-2030 US Healthcare Journal en PressRelease 2026-05-08T15:11:43+00:00 The market for Attention Deficit Hyperactivity Disorder (ADHD) therapeutics is projected to US $17.85 billion by 2030. https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/786757-tbrc-1024x302.jpeg https://www.ushealthcarejournal.com/article/911386021-global-market-report-on-autacoids-and-related-drugs-2026-business-expansion-influencing-factors-trends-through-2030 US Healthcare Journal en PressRelease 2026-05-08T15:11:43+00:00 Global Market Report on Autacoids and Related Drugs 2026: Business Expansion, Influencing Factors, Trends Through 2030 https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/786757-tbrc-1024x302.jpeg https://www.ushealthcarejournal.com/article/911380392-aryl-hydrocarbon-receptor-market-drivers-2026-2030-analysis-of-regional-trends-and-market-size US Healthcare Journal en PressRelease 2026-05-08T15:11:42+00:00 Aryl Hydrocarbon Receptor Market Drivers 2026-2030: Analysis of Regional Trends and Market Size https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/786757-tbrc-1024x302.jpeg https://www.ushealthcarejournal.com/article/911378227-the-artery-stenosis-drug-market-is-projected-to-grow-to-3-46-billion-by-2030-expanding-at-a-5-9-compound-growth-rate US Healthcare Journal en PressRelease 2026-05-08T15:11:41+00:00 The Artery Stenosis Drug Market is projected to grow to $3.46 billion by 2030, expanding at a 5.9% compound growth rate. https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/786757-tbrc-1024x302.jpeg https://www.ushealthcarejournal.com/article/911379413-the-artificial-intelligence-ai-in-biopharmaceuticals-market-to-usd-8-77-billion-by-2030-growth-rate-of-33-1 US Healthcare Journal en PressRelease 2026-05-08T15:11:41+00:00 The Artificial Intelligence (AI) in Biopharmaceuticals Market to USD 8.77 billion by 2030, growth rate of 33.1%. https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/786757-tbrc-1024x302.jpeg https://www.ushealthcarejournal.com/article/911341933-antivenom-market-projected-to-reach-2-91-billion-by-2030-comprehensive-report-from-the-business-research-company US Healthcare Journal en PressRelease 2026-05-08T15:11:40+00:00 Antivenom Market Projected to Reach $2.91 Billion by 2030 - Comprehensive Report from The Business Research Company https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/786757-tbrc-1024x302.jpeg https://www.ushealthcarejournal.com/article/911375349-anxiety-disorders-and-depression-treatment-market-report-analysis-of-competition-and-future-opportunities US Healthcare Journal en PressRelease 2026-05-08T15:11:40+00:00 Anxiety Disorders and Depression Treatment Market Report: Analysis of Competition and Future Opportunities https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/786757-tbrc-1024x302.jpeg https://www.ushealthcarejournal.com/article/911376332-the-appetite-stimulant-market-is-projected-to-grow-to-2-85-billion-by-2030 US Healthcare Journal en PressRelease 2026-05-08T15:11:40+00:00 The Appetite Stimulant Market is projected to grow to $2.85 billion by 2030 https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/786757-tbrc-1024x302.jpeg https://www.ushealthcarejournal.com/article/911340012-antisense-and-rnai-therapeutics-market-2026-2030-exploring-growth-trends-and-recent-developments US Healthcare Journal en PressRelease 2026-05-08T15:11:39+00:00 Antisense and RNAi Therapeutics Market 2026-2030: Exploring Growth Trends and Recent Developments https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/786757-tbrc-1024x302.jpeg https://www.ushealthcarejournal.com/article/911340873-report-on-the-anti-thyroid-drugs-market-size-share-competitive-landscape-and-trend-analysis US Healthcare Journal en PressRelease 2026-05-08T15:11:39+00:00 Report on the Anti-Thyroid Drugs Market: Size, Share, Competitive Landscape, and Trend Analysis https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/786757-tbrc-1024x302.jpeg https://www.ushealthcarejournal.com/article/911335649-autoimmune-gastrointestinal-dysmotility-market-to-hit-usd-2-62b-by-2030-growing-at-an-8-2-cagr US Healthcare Journal en PressRelease 2026-05-08T15:11:38+00:00 Autoimmune Gastrointestinal Dysmotility Market to hit USD 2.62B by 2030, growing at an 8.2% CAGR. https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/786757-tbrc-1024x302.jpeg https://www.ushealthcarejournal.com/article/911336251-autologous-stem-non-stem-cell-therapies-market-2026-2030-growth-trends-key-developments US Healthcare Journal en PressRelease 2026-05-08T15:11:38+00:00 Autologous Stem & Non-Stem Cell Therapies Market 2026-2030: Growth Trends & Key Developments https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/786757-tbrc-1024x302.jpeg https://www.ushealthcarejournal.com/article/911334847-atypical-hemolytic-uremic-syndrome-treatment-market-to-hit-2-45b-by-2030-at-7-2-cagr US Healthcare Journal en PressRelease 2026-05-08T15:11:37+00:00 Atypical Hemolytic Uremic Syndrome Treatment Market to hit $2.45B by 2030 at 7.2% CAGR https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/786757-tbrc-1024x302.jpeg https://www.ushealthcarejournal.com/article/911326542-the-antipyretic-drugs-for-children-market-is-projected-to-grow-to-usd-4-61-billion-by-2030-expanding-at-a-cagr-of-6-3 US Healthcare Journal en PressRelease 2026-05-08T15:11:35+00:00 The Antipyretic Drugs for Children Market is projected to grow to USD 4.61 billion by 2030, expanding at a CAGR of 6.3% https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/786757-tbrc-1024x302.jpeg https://www.ushealthcarejournal.com/article/911327087-antiseptic-bathing-products-market-trends-2026-2030-regional-perspectives-and-size-assessment US Healthcare Journal en PressRelease 2026-05-08T15:11:35+00:00 Antiseptic Bathing Products Market Trends 2026-2030: Regional Perspectives and Size Assessment https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/786757-tbrc-1024x302.jpeg https://www.ushealthcarejournal.com/article/911325444-the-antimetabolite-drug-market-is-projected-to-grow-to-12-23-billion-by-2030 US Healthcare Journal en PressRelease 2026-05-08T15:11:34+00:00 The Antimetabolite Drug Market is Projected to Grow to $12.23 Billion by 2030 https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/786757-tbrc-1024x302.jpeg https://www.ushealthcarejournal.com/article/911325719-the-antipsychotic-drugs-market-is-projected-to-grow-to-usd-33-25-billion-by-2030-expanding-at-a-cagr-of-9-4 US Healthcare Journal en PressRelease 2026-05-08T15:11:34+00:00 The Antipsychotic Drugs Market is projected to grow to USD 33.25 Billion by 2030, expanding at a CAGR of 9.4% https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/786757-tbrc-1024x302.jpeg https://www.ushealthcarejournal.com/article/911326147-the-antiparasitic-drugs-market-is-projected-to-grow-to-36-13-billion-by-2030-expanding-at-a-cagr-of-7-4 US Healthcare Journal en PressRelease 2026-05-08T15:11:34+00:00 The Antiparasitic Drugs Market is projected to grow to $36.13 billion by 2030, expanding at a CAGR of 7.4% https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/786757-tbrc-1024x302.jpeg https://www.ushealthcarejournal.com/article/911324523-anti-inflammatory-biologics-market-analysis-current-competition-and-future-opportunities US Healthcare Journal en PressRelease 2026-05-08T15:11:33+00:00 Anti-Inflammatory Biologics Market Analysis: Current Competition and Future Opportunities https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/786757-tbrc-1024x302.jpeg https://www.ushealthcarejournal.com/article/911302266-analysis-report-on-the-anti-inflammatory-therapeutics-industry-2026-major-trends-growth-factors-and-forecast-overview US Healthcare Journal en PressRelease 2026-05-08T15:11:32+00:00 Analysis Report on the Anti-Inflammatory Therapeutics Industry 2026: Major Trends, Growth Factors, and Forecast Overview https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/786757-tbrc-1024x302.jpeg https://www.ushealthcarejournal.com/article/911303289-the-antiobesity-market-is-projected-to-reach-6-55-billion-by-2030-growing-at-a-10-cagr US Healthcare Journal en PressRelease 2026-05-08T15:11:32+00:00 The Antiobesity Market is Projected to Reach $6.55 Billion by 2030, Growing at a 10% CAGR https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/786757-tbrc-1024x302.jpeg https://www.ushealthcarejournal.com/article/911301669-trends-and-analysis-of-the-anti-hypertensive-drugs-market-by-application-industry-region-with-forecasts-through-2030 US Healthcare Journal en PressRelease 2026-05-08T15:11:31+00:00 Trends and Analysis of the Anti-Hypertensive Drugs Market by Application, Industry, Region, with Forecasts through 2030 https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/786757-tbrc-1024x302.jpeg https://www.ushealthcarejournal.com/article/911117297-androgenetic-alopecia-treatment-market-application-industry-regional-analysis-with-segment-forecasts-to-2030 US Healthcare Journal en PressRelease 2026-05-08T15:11:29+00:00 Androgenetic Alopecia Treatment Market: Application, Industry & Regional Analysis with Segment Forecasts to 2030 https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/786757-tbrc-1024x302.jpeg https://www.ushealthcarejournal.com/article/911388000-about-you-family-medicine-opens-new-midtown-atlanta-location US Healthcare Journal en PressRelease 2026-05-08T14:45:56+00:00 About You Family Medicine Opens New Midtown Atlanta Location https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24851248-ayfm-logo-3105x3105.png https://www.ushealthcarejournal.com/article/911176091-indy-based-firm-is-advising-brands-to-better-connect-with-fans-unlock-more-value-sports-sponsorships US Healthcare Journal en PressRelease 2026-05-08T14:16:40+00:00 Indy-Based Firm is Advising Brands To Better Connect with Fans, Unlock More Value Sports Sponsorships https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24850604-bam-sports-logo-1892x452.png https://www.ushealthcarejournal.com/article/910239794-village-green-addresses-new-dementia-care-delivery-approaches US Healthcare Journal en PressRelease 2026-05-08T14:00:00+00:00 Village Green Addresses New Dementia Care Delivery Approaches https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24846785-assisted-living-facilities-in-m-1536x2048.jpeg https://www.ushealthcarejournal.com/article/910907972-akribis-veins-vitality-highlights-laser-skin-resurfacing-for-smoother-healthier-looking-skin US Healthcare Journal en PressRelease 2026-05-08T14:00:00+00:00 Akribis Veins & Vitality Highlights Laser Skin Resurfacing for Smoother, Healthier Looking Skin https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24849536-laser-skin-resurfacing-at-akrib-1067x843.png https://www.ushealthcarejournal.com/article/911169930-employers-are-expanding-reproductive-health-benefits-yet-63-still-don-t-stock-free-period-products-new-report-finds US Healthcare Journal en PressRelease 2026-05-08T13:57:26+00:00 Employers Are Expanding Reproductive Health Benefits, Yet 63% Still Don't Stock Free Period Products, New Report Finds https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24851195-a-logo-of-reproductive-and-mate-1800x750.png https://www.ushealthcarejournal.com/article/911238721-durkin-entertainment-presents-ecoluxe-best-mother-s-day-gifts US Healthcare Journal en PressRelease 2026-05-08T13:35:34+00:00 Durkin Entertainment Presents ECOLUXE 'Best Mother's Day Gifts' https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24850737-ecoluxe-best-mother-s-day-gift-1120x630.png https://www.ushealthcarejournal.com/article/911373590-precision-oncology-market-size-to-reach-usd-230-40-billion-by-2032-driven-by-genomics-and-precision-oncology US Healthcare Journal en PressRelease 2026-05-08T13:33:10+00:00 Precision Oncology Market Size to Reach USD 230.40 Billion by 2032, Driven by Genomics and Precision Oncology https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24851201-precision-oncology-market-graph-900x580.png https://www.ushealthcarejournal.com/article/911523470-ispecimen-inc-announces-pricing-of-approximately-2-5-million-private-placement US Healthcare Journal en PressRelease 2026-05-09T01:04:00+00:00 iSpecimen Inc. Announces Pricing of Approximately $2.5 Million Private Placement https://ml.globenewswire.com/media/MWMwZjE2YjEtYTE0Yy00NGY4LTljODctMDk0YTk0ZmI5N2E5LTUwMDEzMTIwMy0yMDI2LTA1LTA5LWVu/tiny/iSpecimen-Inc-.png https://www.ushealthcarejournal.com/article/910292616-stanton-optical-breaks-new-ground-in-wichita-falls-tx US Healthcare Journal en PressRelease 2026-05-08T13:00:00+00:00 Stanton Optical breaks new ground in Wichita Falls, TX  https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24848403-367-wichita-falls-store-staff-1200x628.jpeg https://www.ushealthcarejournal.com/article/911366640-biobase-and-techcyte-partner-to-advance-digital-pathology-and-unlock-the-full-potential-of-clinical-data US Healthcare Journal en PressRelease 2026-05-08T12:57:27+00:00 Biobase and Techcyte partner to advance digital pathology and unlock the full potential of clinical data https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24851178-biobase-1200x600.jpeg https://www.ushealthcarejournal.com/article/911523439-open-peer-review-exposes-upv-ethics-committee-s-dilemma-suppress-a-33-year-recognized-breakthrough-or-acknowledge-reviewer-s-ethical-violations-and US Healthcare Journal en PressRelease 2026-05-09T00:24:14+00:00 Open Peer-Review Exposes UPV Ethics Committee’s Dilemma: Suppress a 33 Year Recognized Breakthrough or Acknowledge Reviewer’s Ethical Violations and Remit Final Judgement to the Known Dataset Test to Save Millions of Lives and Billions of Euros https://ml.globenewswire.com/media/40547009-5c5a-4f07-8621-de7e67578439/small/crosetto-foundation-logo-265-pixels-jpg.jpg https://www.ushealthcarejournal.com/article/911079044-cord-for-life-completes-phase-1-dosing-in-fda-authorized-sacroiliac-joint-sij-syndrome-clinical-tria US Healthcare Journal en PressRelease 2026-05-08T11:58:33+00:00 CORD FOR LIFE® COMPLETES PHASE 1 DOSING IN FDA AUTHORIZED SACROILIAC JOINT (SIJ) SYNDROME - CLINICAL TRIA https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24850078-clinical-trial-image-1254x1254.png https://www.ushealthcarejournal.com/article/911344877-advantage-celebrates-multiple-national-bestseller-list-placements-across-its-publishing-portfolio US Healthcare Journal en PressRelease 2026-05-08T11:30:00+00:00 Advantage Celebrates Multiple National Bestseller List Placements Across Its Publishing Portfolio https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24851120-advantage-the-authority-compa-865x618.png https://www.ushealthcarejournal.com/article/911490631-fda-expands-approval-of-vyvgart-and-vyvgart-hytrulo-to-all-adults-living-with-generalized-myasthenia-gravis US Healthcare Journal en PressRelease 2026-05-08T22:27:12+00:00 FDA Expands Approval of VYVGART and VYVGART Hytrulo to All Adults Living with Generalized Myasthenia Gravis https://ml.globenewswire.com/media/YjJmNDYwNjUtMzcyOS00OGUxLTlhZGEtNDU1NmI4YjQxMTE1LTEwOTg0NjYtMjAyNi0wNS0wOC1lbg==/tiny/Muscular-Dystrophy-Association.png https://www.ushealthcarejournal.com/article/911270369-china-top-3-vacuum-homogenizer-emulsifier-mixer-manufacturer-in-2026-leading-industrial-innovation-and-development US Healthcare Journal en PressRelease 2026-05-08T09:43:12+00:00 China Top 3 Vacuum Homogenizer Emulsifier Mixer Manufacturer in 2026: Leading Industrial Innovation and Development https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24850835-logo-for-wuxi-yk-automation-tec-800x800.png https://www.ushealthcarejournal.com/article/911331030-contact-lenses-market-to-reach-usd-14-8-billion-by-2034-growing-at-4-92-cagr US Healthcare Journal en PressRelease 2026-05-08T09:39:27+00:00 Contact Lenses Market to Reach USD 14.8 Billion by 2034, Growing at 4.92% CAGR https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24851070-contact-lenses-market-report-1381x752.png https://www.ushealthcarejournal.com/article/911474620-fda-grants-seventh-approval-under-the-national-priority-voucher-pilot-program US Healthcare Journal en PressRelease 2026-05-08T21:00:59+00:00 FDA Grants Seventh Approval under the National Priority Voucher Pilot Program https://ml.globenewswire.com/media/M2FmNTlkNzctMTZlNi00NzQwLTk2OTctN2NmY2JiYzZhNTExLTUwMDE1NDE1NC0yMDI2LTA1LTA4LWVu/tiny/FDA.png https://www.ushealthcarejournal.com/article/911316836-femometer-smart-ring-air-silver-edition-now-available-for-pre-sale US Healthcare Journal en PressRelease 2026-05-08T08:30:59+00:00 Femometer Smart Ring Air Silver Edition Now Available for Pre-Sale https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24851000-femometer-smart-ring-2048x2048.png https://www.ushealthcarejournal.com/article/911474191-fulcrum-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 US Healthcare Journal en PressRelease 2026-05-08T20:30:00+00:00 Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/3434fc83-4bcf-4d3c-ae26-23e5b1fd4252/small/fulcrum-logo-primary-full-color-rgb-large-png.png https://www.ushealthcarejournal.com/article/911474276-mink-therapeutics-to-report-first-quarter-2026-financial-results-and-highlight-platform-progress-across-inkt-cell-therapy-programs US Healthcare Journal en PressRelease 2026-05-08T20:30:00+00:00 MiNK Therapeutics to Report First Quarter 2026 Financial Results and Highlight Platform Progress Across iNKT Cell Therapy Programs https://ml.globenewswire.com/media/6aa8e960-515a-40d6-9894-39ca47f5c84e/small/mink-logo-loyal-blue-and-light-blue-png.png https://www.ushealthcarejournal.com/article/911474434-azalea-therapeutics-announces-late-breaking-oral-presentation-at-asgct-annual-meeting-demonstrating-first-in-primate-in-vivo-trac-car-t-cell US Healthcare Journal en PressRelease 2026-05-08T20:30:00+00:00 Azalea Therapeutics Announces Late-Breaking Oral Presentation at ASGCT Annual Meeting Demonstrating First-in-Primate In Vivo TRAC-CAR T Cell Engineering https://ml.globenewswire.com/media/074db8ed-c280-47d0-8c17-f1980e6b4ad3/small/azalea-therapeutics-logo-1200x353-png.png https://www.ushealthcarejournal.com/article/911474524-fda-issues-guidance-to-improve-collection-of-pregnancy-safety-data-for-drugs-and-biologics US Healthcare Journal en PressRelease 2026-05-08T20:24:44+00:00 FDA Issues Guidance to Improve Collection of Pregnancy Safety Data for Drugs and Biologics https://ml.globenewswire.com/media/MDU4NGIzYzgtOWZkYy00MmNkLWJkYTAtZjMxYzAwMmMxYTE0LTUwMDE1NDE1NC0yMDI2LTA1LTA4LWVu/tiny/FDA.png https://www.ushealthcarejournal.com/article/911312670-accurate-quantification-of-bacterial-endotoxins-using-betmat-s-kinetic-chromogenic-lal-assay US Healthcare Journal en PressRelease 2026-05-08T08:17:33+00:00 Accurate Quantification of Bacterial Endotoxins Using BETMAT’s Kinetic Chromogenic LAL Assay https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24851003-kca-product-324x323.png https://www.ushealthcarejournal.com/article/911474196-vera-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4 US Healthcare Journal en PressRelease 2026-05-08T20:05:00+00:00 Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/25b71017-1f55-4adb-9d6a-17c2ba55b36e/small/cropped-logo-digital-png.png https://www.ushealthcarejournal.com/article/911474206-femasys-announces-financial-results-for-quarter-ended-march-31-2026-and-provides-corporate-update US Healthcare Journal en PressRelease 2026-05-08T20:05:00+00:00 Femasys Announces Financial Results for Quarter Ended March 31, 2026 and Provides Corporate Update https://ml.globenewswire.com/media/c668c3db-ff7f-4eb5-b51a-b8db25e838b4/small/femasys-logo-2-jpg.jpg https://www.ushealthcarejournal.com/article/911474273-ocular-therapeutix-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 US Healthcare Journal en PressRelease 2026-05-08T20:05:00+00:00 Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/20ee0f50-7288-4f81-8546-f2ad2050ddbf/small/ocul-logo-jpg.jpg https://www.ushealthcarejournal.com/article/911474329-tomi-environmental-solutions-inc-reports-first-quarter-2026-financial-results-and-announces-transformative-letter-of-intent-to-merge-with-carbonium US Healthcare Journal en PressRelease 2026-05-08T20:05:00+00:00 TOMI Environmental Solutions, Inc. Reports First Quarter 2026 Financial Results and Announces Transformative Letter of Intent to Merge with Carbonium Core, Inc. https://ml.globenewswire.com/media/f8c7c513-0121-4507-84b7-3680626d9cf3/small/tomi-jpg.jpg https://www.ushealthcarejournal.com/article/911474339-longeveron-announces-constructive-type-c-meeting-with-u-s-fda-ahead-of-data-readout-for-elpis-ii-phase-2b-clinical-trial-evaluating-treatment-for US Healthcare Journal en PressRelease 2026-05-08T20:05:00+00:00 Longeveron Announces Constructive Type C Meeting with U.S. FDA Ahead of Data Readout for ELPIS II Phase 2b Clinical Trial Evaluating Treatment for Hypoplastic Left Heart Syndrome (HLHS) https://ml.globenewswire.com/media/a6d6e61c-2a7d-4b22-954b-04b9841fbc38/small/longeveron-logo-jpg.jpg https://www.ushealthcarejournal.com/article/911474376-james-cacioppo-files-updated-early-warning-report US Healthcare Journal en PressRelease 2026-05-08T20:05:00+00:00 James Cacioppo Files Updated Early Warning Report https://ml.globenewswire.com/media/e65f15fd-322c-4847-83c5-ceafe27f97d5/small/jushi-png.png https://www.ushealthcarejournal.com/article/911474203-bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 US Healthcare Journal en PressRelease 2026-05-08T20:01:00+00:00 BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/2074ba9b-0e5b-41fa-baac-553f1345bb75/small/bridge-bio-black-png.png https://www.ushealthcarejournal.com/article/911474472-biofrontera-inc-to-report-first-quarter-2026-financial-results-and-host-a-conference-call-on-may-14-2026 US Healthcare Journal en PressRelease 2026-05-08T20:00:00+00:00 Biofrontera Inc. to Report First Quarter 2026 Financial Results and Host a Conference Call on May 14, 2026 https://ml.globenewswire.com/media/4af5197e-340e-4307-892b-382a1d29ae45/small/logo-png.png https://www.ushealthcarejournal.com/article/911457438-shiny-smile-veneers-under-investigation-evaluating-the-dentist-designed-custom-fit-snap-on-top-bottom-veneer-claims US Healthcare Journal en PressRelease 2026-05-08T19:51:07+00:00 Shiny Smile Veneers Under Investigation: Evaluating the Dentist-Designed Custom Fit Snap-On Top & Bottom Veneer Claims https://zingfast.com/wp-content/uploads/2026/05/Shiny-Smile-Veneers.jpg https://www.ushealthcarejournal.com/article/911311006-cloud-clone-advances-global-antibody-solutions-for-life-science-research-and-in-vitro-diagnostics US Healthcare Journal en PressRelease 2026-05-08T07:36:45+00:00 Cloud-Clone Advances Global Antibody Solutions for Life Science Research and In Vitro Diagnostics https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24850984-figure-1-cloud-clone-spf-grade-841x631.png https://www.ushealthcarejournal.com/article/911310463-knoxville-pediatric-dentist-explains-modern-treatments-that-help-prevent-and-treat-childhood-cavities US Healthcare Journal en PressRelease 2026-05-08T07:31:00+00:00 Knoxville Pediatric Dentist Explains Modern Treatments That Help Prevent and Treat Childhood Cavities https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24850983-front-entrance-at-the-office-of-2048x1529.jpeg https://www.ushealthcarejournal.com/article/911136952-ank-behavioral-health-launches-new-website-to-enhance-access-to-psychiatric-care-in-new-jersey US Healthcare Journal en PressRelease 2026-05-08T07:30:00+00:00 ANK Behavioral Health Launches New Website to Enhance Access to Psychiatric Care in New Jersey https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24850403-smiling-african-american-female-2048x1463.jpeg https://www.ushealthcarejournal.com/article/911457434-fitness-online-named-best-fitness-mobile-app-in-10th-annual-medtech-breakthrough-awards-program US Healthcare Journal en PressRelease 2026-05-08T19:29:53+00:00 Fitness Online Named “Best Fitness Mobile App” in 10th Annual MedTech Breakthrough Awards Program https://ml.globenewswire.com/media/27a7520b-9ae6-414c-ae9d-5267dc364671/small/medtech-png.png https://www.ushealthcarejournal.com/article/911292196-digitalxforce-accelerates-toward-100m-arr-milestone-amid-strong-demand-and-strategic-investor-interest US Healthcare Journal en PressRelease 2026-05-08T06:02:36+00:00 DigitalXForce Accelerates Toward $100M ARR Milestone Amid Strong Demand and Strategic Investor Interest https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24331996-lalit-k-ahluwalia-ceo-new-512x512.jpeg https://www.ushealthcarejournal.com/article/911291380-spectra-executes-large-scale-mailing-for-medicare-advisory-service US Healthcare Journal en PressRelease 2026-05-08T06:02:35+00:00 SPECTRA EXECUTES LARGE-SCALE MAILING FOR MEDICARE ADVISORY SERVICE https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24850906-hipaa-compliant-1400x788.png https://www.ushealthcarejournal.com/article/911439926-more-life-summit-2026-brings-the-world-s-leading-voices-in-longevity-performance-faith-purpose-to-miami-this-october US Healthcare Journal en PressRelease 2026-05-08T17:12:36+00:00 More Life Summit 2026 Brings the World's Leading Voices in Longevity, Performance, Faith & Purpose to Miami this October https://ml.globenewswire.com/media/6f384cad-1646-4d58-bf63-e08230833288/medium/more-life-summit-2026-miami-fl.png https://www.ushealthcarejournal.com/article/911404291-cytokinetics-announces-closing-of-public-offering-of-common-stock-and-full-exercise-of-the-underwriters-option-to-purchase-additional-shares-for US Healthcare Journal en PressRelease 2026-05-08T14:51:36+00:00 Cytokinetics Announces Closing of Public Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $805 Million https://ml.globenewswire.com/media/52e2be9f-e9e3-43af-a747-123fdcac4253/small/cytokinetics-png.png https://www.ushealthcarejournal.com/article/911386290-inspire-named-best-patient-experience-platform-in-10th-annual-medtech-breakthrough-awards-program US Healthcare Journal en PressRelease 2026-05-08T14:10:00+00:00 Inspire Named “Best Patient Experience Platform” in 10th Annual MedTech Breakthrough Awards Program https://ml.globenewswire.com/media/OWVkODQ2MTktZDk0YS00M2Q0LWJlYmItYTIyYTRjMTgxZDUzLTUwMDEyOTE4NC0yMDI2LTA1LTA4LWVu/tiny/Inspire.png https://www.ushealthcarejournal.com/article/911386518-ai-technology-transforms-cannabis-industry-as-leading-operators-drive-adoption-to-enhance-yields-and-compliance US Healthcare Journal en PressRelease 2026-05-08T13:52:16+00:00 AI Technology Transforms Cannabis Industry as Leading Operators Drive Adoption to Enhance Yields and Compliance https://ml.globenewswire.com/media/d0c282b6-d496-45a8-a941-33fa5c3e824c/small/bcc-logo-1200-630-png.png https://www.ushealthcarejournal.com/article/911386301-merit-medical-to-participate-in-the-bank-of-america-healthcare-conference US Healthcare Journal en PressRelease 2026-05-08T13:25:00+00:00 Merit Medical to Participate in the Bank of America Healthcare Conference https://ml.globenewswire.com/media/19958d8f-47a4-44f3-a780-247335a68768/small/merit-medical-systems-inc-logo.jpg https://www.ushealthcarejournal.com/article/911386310-envue-medical-adds-to-intellectual-property-portfolio-by-securing-uspto-notice-of-allowance-for-ultrasound-enhanced-cannabinoid-drug-delivery US Healthcare Journal en PressRelease 2026-05-08T13:15:00+00:00 ENvue Medical Adds to Intellectual Property Portfolio by Securing USPTO Notice of Allowance for Ultrasound-Enhanced Cannabinoid Drug Delivery Technology https://ml.globenewswire.com/media/e0a97028-a7c3-4dd6-a13f-a55e43617883/small/logo-small-722-jpg.jpg https://www.ushealthcarejournal.com/article/911370850-alpha-tau-to-host-conference-call-to-discuss-interim-results-from-first-three-patients-treated-for-recurrent-glioblastoma US Healthcare Journal en PressRelease 2026-05-08T13:10:00+00:00 Alpha Tau to Host Conference Call to Discuss Interim Results from First Three Patients Treated for Recurrent Glioblastoma https://ml.globenewswire.com/media/a9de6f03-a487-4934-98e9-d25cdb4c8bed/small/atm-logo-jpg.jpg https://www.ushealthcarejournal.com/article/911370587-bioage-labs-reports-first-quarter-2026-financial-results-and-provides-business-updates US Healthcare Journal en PressRelease 2026-05-08T13:00:00+00:00 BioAge Labs Reports First Quarter 2026 Financial Results and Provides Business Updates https://ml.globenewswire.com/media/d6df9eb5-87f7-4e2e-b503-8a7d8651428e/small/bioage-dark-logo-white-bg-500x500-png.png https://www.ushealthcarejournal.com/article/911370826-alpha-tau-completes-patient-enrollment-in-its-u-s-pivotal-skin-cancer-study-advancing-towards-goal-of-fda-approval-of-alpha-dart-to-treat-recurrent US Healthcare Journal en PressRelease 2026-05-08T13:00:00+00:00 Alpha Tau Completes Patient Enrollment in its U.S. Pivotal Skin Cancer Study, Advancing Towards Goal of FDA Approval of Alpha DaRT® to Treat Recurrent Cutaneous Squamous Cell Carcinoma https://ml.globenewswire.com/media/a9de6f03-a487-4934-98e9-d25cdb4c8bed/small/atm-logo-jpg.jpg https://www.ushealthcarejournal.com/article/911370672-moleculin-biotech-secures-strategic-additional-patent-strengthening-global-positioning-of-annamycin US Healthcare Journal en PressRelease 2026-05-08T12:45:00+00:00 Moleculin Biotech Secures Strategic Additional Patent, Strengthening Global Positioning of Annamycin https://ml.globenewswire.com/media/7fa09722-2ef8-49fc-bc24-6b150093f8ba/small/mbrx-logo-png.png https://www.ushealthcarejournal.com/article/911371106-aim-immunotech-inc-announces-exercise-of-warrants-for-approx-4-2-million-in-gross-proceeds US Healthcare Journal en PressRelease 2026-05-08T12:40:00+00:00 AIM ImmunoTech, Inc. Announces Exercise of Warrants for Approx. $4.2 Million in Gross Proceeds https://ml.globenewswire.com/media/8e85b83b-047f-4f99-9c51-1aa232ffe9bb/small/aimlogo-jpg.jpg https://www.ushealthcarejournal.com/article/911370349-aclaris-therapeutics-to-participate-in-the-2026-bank-of-america-healthcare-conference US Healthcare Journal en PressRelease 2026-05-08T12:30:00+00:00 Aclaris Therapeutics to Participate in the 2026 Bank of America Healthcare Conference https://ml.globenewswire.com/media/de2bcb21-de59-4226-bc8b-b1b747461f51/small/aclaris-logo-clr-jpg.jpg https://www.ushealthcarejournal.com/article/911370712-cg-oncology-reports-first-quarter-2026-financial-results-and-provides-business-updates US Healthcare Journal en PressRelease 2026-05-08T12:30:00+00:00 CG Oncology Reports First Quarter 2026 Financial Results and Provides Business Updates https://ml.globenewswire.com/media/9e1cbdea-928e-4ea4-b4cd-33cdc36c6b2f/small/cgoncology-cover-jpg.jpg https://www.ushealthcarejournal.com/article/911064699-predata-ai-announces-friendship-event-kit-for-gatherings-events-up-to-100-people US Healthcare Journal en PressRelease 2026-05-08T00:00:00+00:00 Predata.ai announces Friendship Event Kit for gatherings/events up to 100 people https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24849996-friends-699x432.png https://www.ushealthcarejournal.com/article/911370316-mimedx-announces-launch-of-g4derm-plus US Healthcare Journal en PressRelease 2026-05-08T12:00:00+00:00 MIMEDX Announces Launch of G4Derm® Plus https://ml.globenewswire.com/media/2a60ab36-4917-479c-b53a-4f2113ca347d/small/mimedx-png.png https://www.ushealthcarejournal.com/article/911370607-alx-oncology-reports-first-quarter-2026-financial-results-and-provides-corporate-update US Healthcare Journal en PressRelease 2026-05-08T12:00:00+00:00 ALX Oncology Reports First Quarter 2026 Financial Results and Provides Corporate Update https://ml.globenewswire.com/media/0a1b4459-3df3-4c9f-ba29-ace8d7ad1b9a/small/alx-01-stacked-white-png.png https://www.ushealthcarejournal.com/article/911370619-integra-lifesciences-to-present-at-the-bofa-securities-2026-health-care-conference US Healthcare Journal en PressRelease 2026-05-08T12:00:00+00:00 Integra LifeSciences to Present at the BofA Securities 2026 Health Care Conference https://ml.globenewswire.com/media/80d27f1a-2d8e-44f2-92e9-57e14db38652/small/integra-promotional-logos-integra-logo-full-color-process-1.png https://www.ushealthcarejournal.com/article/911370805-biocardia-and-fda-align-on-helix-transendocardial-delivery-catheter-clearance-pathways US Healthcare Journal en PressRelease 2026-05-08T12:00:00+00:00 BioCardia and FDA Align on Helix Transendocardial Delivery Catheter Clearance Pathways https://ml.globenewswire.com/media/4641bb53-4913-4654-a337-79383a5c7ab9/small/biocardia-final-logo-2016-jpeg-jpg.jpg https://www.ushealthcarejournal.com/article/911370907-alamar-biosciences-reports-first-quarter-2026-financial-results US Healthcare Journal en PressRelease 2026-05-08T12:00:00+00:00 Alamar Biosciences Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/9394cf1d-76c7-4cf9-8ed3-cafcc57c9a84/small/alamardroplogo-4c-png.png https://www.ushealthcarejournal.com/article/911210666-helping-vs-enabling-toolkit-families-dealing-with-addiction-gain-a-new-support-resource US Healthcare Journal en PressRelease 2026-05-07T23:52:10+00:00 Helping vs. Enabling Toolkit: Families Dealing with Addiction Gain a New Support Resource https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24850700-toolkit-graphic-1000x667.jpeg https://www.ushealthcarejournal.com/article/911355251-plus-therapeutics-announces-oral-presentation-highlighting-reyobiq-clinical-and-translational-data-demonstrating-favorable-safety-survival-and US Healthcare Journal en PressRelease 2026-05-08T11:30:00+00:00 Plus Therapeutics Announces Oral Presentation Highlighting REYOBIQ™ Clinical and Translational Data Demonstrating Favorable Safety, Survival, and Emerging Immunomodulation in Leptomeningeal Metastases https://ml.globenewswire.com/media/92d7aa70-e37d-4870-bccf-d83b68ba5612/small/plus-logo-png.png https://www.ushealthcarejournal.com/article/911355689-traws-pharma-to-advance-potential-clinical-candidates-for-the-treatment-of-hantavirus-infections US Healthcare Journal en PressRelease 2026-05-08T11:30:00+00:00 Traws Pharma to Advance Potential Clinical Candidates for the Treatment of Hantavirus Infections https://ml.globenewswire.com/media/1eb1780a-724e-4555-ab4d-455e27d18544/small/traws-pharma-blue-png.png https://www.ushealthcarejournal.com/article/911355617-treace-medical-concepts-reports-first-quarter-2026-financial-results US Healthcare Journal en PressRelease 2026-05-08T11:05:00+00:00 Treace Medical Concepts Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/e6af4ccc-19b1-4fe0-948f-436f2b9d2ea5/small/treace-color-jpg.jpg https://www.ushealthcarejournal.com/article/911212136-beyond-anxiety-by-james-p-gustason-offers-a-practical-three-level-path-to-lasting-anxiety-relief US Healthcare Journal en PressRelease 2026-05-07T23:03:12+00:00 Beyond Anxiety by James P. Gustason Offers a Practical Three-Level Path to Lasting Anxiety Relief https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24850697-beyond-anxiety-by-james-p-gust-348x522.jpeg https://www.ushealthcarejournal.com/article/911355434-lensar-reports-first-quarter-2026-results-and-provides-business-update US Healthcare Journal en PressRelease 2026-05-08T11:00:00+00:00 LENSAR® Reports First Quarter 2026 Results and Provides Business Update https://ml.globenewswire.com/media/4768eddf-0f87-4479-87f6-6b81f8ff392a/small/lensar-4color-jpg.jpg https://www.ushealthcarejournal.com/article/911355605-boundless-bio-reports-first-quarter-2026-financial-results-and-business-highlights US Healthcare Journal en PressRelease 2026-05-08T11:00:00+00:00 Boundless Bio Reports First Quarter 2026 Financial Results and Business Highlights https://ml.globenewswire.com/media/3b8ff619-e7af-4c58-a7f2-de0c4019068d/small/boundlessbiologo-jpg.jpg https://www.ushealthcarejournal.com/article/911355613-regeneron-named-to-dow-jones-best-in-class-world-index-for-global-responsibility-leadership-for-seven-consecutive-years US Healthcare Journal en PressRelease 2026-05-08T11:00:00+00:00 Regeneron Named to Dow Jones Best-in-Class World Index for Global Responsibility Leadership for Seven Consecutive Years https://ml.globenewswire.com/media/add5ebc7-88c9-49dc-8834-abbb07c622d1/small/regeneron-logo-jpg.jpg https://www.ushealthcarejournal.com/article/911355697-maplight-therapeutics-to-participate-in-upcoming-investor-conferences US Healthcare Journal en PressRelease 2026-05-08T11:00:00+00:00 MapLight Therapeutics to Participate in Upcoming Investor Conferences https://ml.globenewswire.com/media/173b471e-5a67-4f12-84f2-06f4980ebd76/small/maplight-logo-horizontal-web-color-png.png https://www.ushealthcarejournal.com/article/911210959-the-role-of-health-coaching-in-patient-outcomes-and-long-term-wellness-support US Healthcare Journal en PressRelease 2026-05-07T22:58:09+00:00 The Role of Health Coaching in Patient Outcomes and Long-Term Wellness Support https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/21184252-dr-care-1920x1280.jpeg https://www.ushealthcarejournal.com/article/911355628-ani-pharmaceuticals-reports-first-quarter-2026-financial-results-and-raises-2026-financial-guidance US Healthcare Journal en PressRelease 2026-05-08T10:50:00+00:00 ANI Pharmaceuticals Reports First Quarter 2026 Financial Results and Raises 2026 Financial Guidance https://ml.globenewswire.com/media/24d1d851-9075-4d6e-b22c-0c23a5ef0b36/small/ani-logo-png.png https://www.ushealthcarejournal.com/article/911165545-university-orthopedics-launches-center-for-clinical-optimization-to-improve-surgical-outcomes-and-reduce-complications US Healthcare Journal en PressRelease 2026-05-07T21:28:49+00:00 University Orthopedics Launches Center for Clinical Optimization to Improve Surgical Outcomes and Reduce Complications https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24850541-uoi-clinical-optimization-2528x1684.png https://www.ushealthcarejournal.com/article/911171012-oley-health-to-present-wellness-products-at-world-health-event US Healthcare Journal en PressRelease 2026-05-07T21:16:42+00:00 Oley Health to Present Wellness Products at World Health Event https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24850629-world-council-for-health-and-o-1942x809.png https://www.ushealthcarejournal.com/article/911102923-social-isolation-poses-health-risk-comparable-to-smoking-worcester-library-program-offers-a-powerful-local-solution US Healthcare Journal en PressRelease 2026-05-07T20:49:45+00:00 Social Isolation Poses Health Risk Comparable to Smoking—Worcester Library Program Offers a Powerful Local Solution https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24850252-senior-group-reading-together-1890x1534.png https://www.ushealthcarejournal.com/article/911268606-lifestance-health-group-announces-pricing-of-secondary-public-offering US Healthcare Journal en PressRelease 2026-05-08T02:18:18+00:00 LifeStance Health Group Announces Pricing of Secondary Public Offering https://ml.globenewswire.com/media/08b345f0-a6a4-4217-9255-cce40df2585c/small/lifestance-logo-png.png https://www.ushealthcarejournal.com/article/911254150-mobia-medical-announces-pricing-of-initial-public-offering US Healthcare Journal en PressRelease 2026-05-08T02:10:05+00:00 Mobia Medical Announces Pricing of Initial Public Offering https://ml.globenewswire.com/media/52324ae5-4190-4acb-93b4-aa6f1c996843/small/mobia-medical-logo-color-rgb-400x400-png.png https://www.ushealthcarejournal.com/article/911239138-odyssey-therapeutics-announces-pricing-of-upsized-initial-public-offering US Healthcare Journal en PressRelease 2026-05-08T00:44:45+00:00 Odyssey Therapeutics Announces Pricing of Upsized Initial Public Offering https://ml.globenewswire.com/media/6da00a97-4976-4d32-9f38-cff9c4f091cf/small/odysseylogo-color-highres-png.png https://www.ushealthcarejournal.com/article/911222901-cue-biopharma-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 US Healthcare Journal en PressRelease 2026-05-07T23:07:21+00:00 Cue Biopharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/10541379-34cc-4869-a26f-fd99feead42a/small/cue-bio-brand-strategy-graphics-jpg.jpg https://www.ushealthcarejournal.com/article/911222877-novi-glp-1-weight-loss-claims-evaluated-trusted-semaglutide-tirzepatide-prescription-medication-treatment-options-with-dedicated-doctors US Healthcare Journal en PressRelease 2026-05-07T22:50:39+00:00 Novi GLP-1 Weight Loss Claims Evaluated: Trusted Semaglutide & Tirzepatide Prescription Medication Treatment Options with Dedicated Doctors https://zingfast.com/wp-content/uploads/2026/05/Novi-GLP-1-Weight-Loss.jpg https://www.ushealthcarejournal.com/article/911190966-lemaitre-to-present-at-the-bank-of-america-healthcare-conference US Healthcare Journal en PressRelease 2026-05-07T21:15:30+00:00 LeMaitre to Present at the Bank of America Healthcare Conference https://ml.globenewswire.com/media/8b8755b7-6f04-4650-9c94-0a2d0654fd49/small/lemaitre-2color-rgb-jpg.jpg https://www.ushealthcarejournal.com/article/911190801-tarsus-to-participate-in-upcoming-investor-conferences US Healthcare Journal en PressRelease 2026-05-07T21:00:00+00:00 Tarsus to Participate in Upcoming Investor Conferences https://ml.globenewswire.com/media/22d429f7-9b81-4c03-a147-1d9cbc86d1dd/small/tarsus-logo-stacked-color-532x626-png.png https://www.ushealthcarejournal.com/article/911190911-lifestance-health-group-announces-launch-of-secondary-public-offering US Healthcare Journal en PressRelease 2026-05-07T20:51:06+00:00 LifeStance Health Group Announces Launch of Secondary Public Offering https://ml.globenewswire.com/media/08b345f0-a6a4-4217-9255-cce40df2585c/small/lifestance-logo-png.png